Table 4 Cause-specific risk models for ESKD and death before ESKD in high-risk participants.
From: Long-term risk for end-stage kidney disease and death in a large population-based cohort
Obese | Hypertensive | Diabetic | ||||
|---|---|---|---|---|---|---|
ESKD | Death before ESKD | ESKD | Death before ESKD | ESKD | Death before ESKD | |
Risk Factor | HR | HR | HR | HR | HR | HR |
(95% CI) | (95% CI) | (95% CI) | (95% CI) | (95% CI) | (95% CI) | |
Cases / n | 83/20,137 | 3,347/20,137 | 271/65,555 | 13,532/65,555 | 78/6,219 | 2,028/6,168 |
Smoking status [smokers vs. non-smokers] | 1.27 | 1.25 | 1.44 | 1.36 | 1.71 | 1.25 |
(0.79–2.03) | (1.15–1.36) | (1.11–1.87) | (1.34–1.45) | (1.05–2.78) | (1.13–1.39) | |
BMI [kg/m2] | 1.04 | 1.04 | 0.99 | 1.00 | 1.02 | 1.00 |
(0.98–1.10) | (1.03–1.05) | (0.96–1.02) | (0.99–1.00) | (0.97–1.06) | (0.99–1.01) | |
Fasting blood glucose [mmol/L] | 1.27 | 1.05 | 1.19 | 1.06 | 1.16 | 1.05 |
(1.20–1.34) | (1.04–1.07) | (1.14–1.23) | (1.06–1.07) | (1.10–1.23) | (1.03–1.06) | |
Systolic blood pressure [5 mmHg] | 1.03 | 1.02 | 1.11 | 1.02 | 1.09 | 1.01 |
(0.96–1.10) | (1.01–1.03) | (1.07–1.15) | (1.02–1.03) | (1.03–1.17) | (1.00–1.02) | |
Diastolic blood pressure [5 mmHg] | 1.18 | 0.99 | 1.06 | 1.00 | 1.06 | 1.01 |
(1.05–1.32) | (0.98–1.01) | (1.00–1.13) | (0.99–1.01) | (0.95–1.19) | (0.99–1.03) | |
Log_triglycerides [mmol/L] | 1.40 | 1.07 | 1.63 | 1.09 | 1.29 | 1.09 |
(0.93–2.11) | (0.99–1.15) | (1.30–2.05) | (1.05–1.13) | (0.87–1.92) | (1.00–1.19) | |
Total cholesterol [mmol/L] | 1.33 | 1.00 | 1.18 | 0.96 | 1.19 | 0.99 |
(1.16–1.51) | (0.97–1.03) | (1.08–1.29) | (0.95–0.98) | (1.05–1.36) | (0.95–1.02) | |
Log_GGT [U/L] | 0.74 | 1.36 | 0.94 | 1.33 | 1.00 | 1.25 |
(0.53–1.05) | (1.29–1.43) | (0.79–1.13) | (1.30–1.36) | (0.74–1.36) | (1.18–1.32) | |
